Incidence and Visual Outcomes of Endophthalmitis After Intravitreal Injection of Dexamethasone Implant vs Ranibizumab.

Maitri PancholyPhilip P StoreyEdward H Wood Varun ChaudharyAnthony ObeidElizabeth MarlowNathan D FarleyJeremy D WolfeSunir J Garg

Published in: Journal of vitreoretinal diseases (2022)

Suspected endophthalmitis might be more common after 0.7 mg dexamethasone injections than after 0.5 mg ranibizumab injections. Culture-positive endophthalmitis rates were similar across all 3 medications.

Keyphrases

age related macular degeneration
diabetic retinopathy
ultrasound guided
cataract surgery
high dose
low dose
platelet rich plasma
vascular endothelial growth factor
pulmonary embolism
optical coherence tomography
insulin resistance